bioMérieux S.A. (EPA:BIM)
France · Delayed Price · Currency is EUR 74.35
+1.10 (1.50%)
May 29, 2026, 5:35 PM CET
bioMérieux Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, bioMérieux stock has a consensus rating of "Buy" and an average price target of €96.51. The average 1-year stock price forecast is 29.80% higher than the current stock price, while the lowest is €71.60 (-3.70%) and the highest is €138.00 (+85.61%).
Price Target: €96.51 (+29.80%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for bioMérieux stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 4 | 3 | 3 |
| Buy | 2 | 0 | 1 | 1 | 1 | 1 |
| Hold | 7 | 8 | 7 | 8 | 9 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 13 | 13 | 13 | 13 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Maintains €138.00 | Buy | Maintains | €138.00 | +85.61% | May 21, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Maintains €120.50 → €71.60 | Hold | Maintains | €120.50 → €71.60 | -3.70% | Apr 24, 2026 |
| Deutsche Bank | Deutsche Bank | Hold Downgrades €120.00 → €81.00 | Hold | Downgrades | €120.00 → €81.00 | +8.94% | Apr 24, 2026 |
| Barclays | Barclays | Hold Maintains €100.00 → €90.00 | Hold | Maintains | €100.00 → €90.00 | +21.05% | Apr 23, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains €109.00 → €100.00 | Hold | Maintains | €109.00 → €100.00 | +34.50% | Apr 14, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.